Factors associated with serum brain natriuretic peptide levels after the fontan procedure

Congenital Heart Disease

Volumn 6, Issue 4, 2011, Pages 313-321

  Atz, Andrew M ^a   Zak, Victor ^b   Breitbart, Roger E ^c   Colan, Steven D ^c   Pasquali, Sara K ^d   Hsu, Daphne T ^e   Lu, Minmin ^b   Mahony, Lynn ^f   Paridon, Stephen M ^g   Puchalski, Michael D ^h   Geva, Tal ^c   McCrindle, Brian W ⁱ  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h UNIVERSITY OF UTAH   (United States)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Congenital heart defects; Fontan procedure; Natriuretic peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; ATRIOPULMONARY CONNECTION; CARDIOVASCULAR MAGNETIC RESONANCE; CHILD; CHRONOTROPISM; CROSS-SECTIONAL STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FONTAN PROCEDURE; HEALTH STATUS; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SCHOOL CHILD; SEX DIFFERENCE; SYSTOLIC DYSFUNCTION; THROMBOSIS;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FONTAN PROCEDURE; HEALTH STATUS; HEART DEFECTS, CONGENITAL; HUMANS; LINEAR MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; ONTARIO; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79960666607     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2011.00496.x     Document Type: Article

References (22)

1. Maisel AS, Clopton P, Krishnaswamy P, etal. Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. Am Heart J. 2004;147:1078-1084.
2. Maisel AS, Krishnaswamy P, Nowak RM, etal. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;18:161-167.
3. Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol. 2005;95:474-478.
4. Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J. 2006;27:861-866.
5. Anderson PA, Sleeper LA, Mahony L, etal. Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol. 2008;52:85-98.
6. Sleeper LA, Anderson P, Hsu DT, etal. Design of a large cross-sectional study to facilitate future clinical trials in children with the Fontan palliation. Am Heart J. 2006;152:427-433.
7. Landgraf JM. Measuring health-related quality of life in pediatric oncology patients: a brief commentary on the state of the art of measurement and application (discussion). Int J Cancer Suppl. 1999;12:147-150.
8. McCrindle BW, Williams RV, Mitchell PD, etal. Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation. 2006;113:1123-1129.
9. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol. 2004;25:341-346.
10. Law YM, Hoyer AW, Reller MD, Silberbach M. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study. J Am Coll Cardiol. 2009;54:1467-1475.
11. Saenger AK, Dalenberg DA, Bryant SC, Grebe SK, Jaffe AS. Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone. Clin Chem. 2009;55:1869-1875.
12. Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart. 2003;89:875-878.
13. Koch AM, Zink S, Singer H, Dittrich S. B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection. Eur J Heart Fail. 2008;10:60-62.
14. Wahlander H, Westerlind A, Lindstedt G, Lundberg PA, Holmgren D. Increased levels of brain and atrial natriuretic peptides after the first palliative operation, but not after a bidirectional Glenn anastomosis, in children with functionally univentricular hearts. Cardiol Young. 2003;13:268-274.
15. Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol. 2006;98:520-524.
16. Ohuchi H, Takasugi H, Ohashi H, etal. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients. Circulation. 2004;110:2601-2608.
17. Lechner E, Gitter R, Mair R, etal. Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure. Pediatr Cardiol. 2008;29:901-905.
18. Lauer MS, Okin PM, Larson MG, Evans JC, Levy D. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation. 1996;93:1520-1526.
19. Norozi K, Wessel A, Alpers V, etal. Chronotropic incompetence in adolescents and adults with congenital heart disease after cardiac surgery. J Card Fail. 2007;13:263-268.
20. Man BL, Cheung YF. Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure. Heart Vessels. 2007;22:398-403.
21. Maron BJ, Tholakanahalli VN, Zenovich AG, etal. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation. 2004;109:984-989.
22. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol. 2004;25:336-340.